- Home
- RVPH vs RAND Comparison
RVPH vs RAND Comparison
Compare RVPH & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- RAND
- Stock Information
- Founded
- RVPH 2006
- RAND 1969
- Country
- RVPH United States
- RAND United States
- Employees
- RVPH N/A
- RAND N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- RVPH Health Care
- RAND Finance
- Exchange
- RVPH Nasdaq
- RAND Nasdaq
- Market Cap
- RVPH 32.8M
- RAND 57.6M
- IPO Year
- RVPH N/A
- RAND N/A
- Fundamental
- Price
- RVPH $0.40
- RAND $17.43
- Analyst Decision
- RVPH Strong Buy
- RAND
- Analyst Count
- RVPH 5
- RAND 0
- Target Price
- RVPH $9.00
- RAND N/A
- AVG Volume (30 Days)
- RVPH 3.4M
- RAND 4.9K
- Earning Date
- RVPH 08-13-2025
- RAND 08-05-2025
- Dividend Yield
- RVPH N/A
- RAND 10.01%
- EPS Growth
- RVPH N/A
- RAND 39.77
- EPS
- RVPH N/A
- RAND 3.12
- Revenue
- RVPH N/A
- RAND $8,499,970.00
- Revenue This Year
- RVPH N/A
- RAND N/A
- Revenue Next Year
- RVPH N/A
- RAND N/A
- P/E Ratio
- RVPH N/A
- RAND $5.60
- Revenue Growth
- RVPH N/A
- RAND 12.52
- 52 Week Low
- RVPH $0.30
- RAND $14.93
- 52 Week High
- RVPH $4.28
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- RVPH 33.44
- RAND 69.52
- Support Level
- RVPH $0.35
- RAND $16.26
- Resistance Level
- RVPH $0.83
- RAND $16.89
- Average True Range (ATR)
- RVPH 0.06
- RAND 0.49
- MACD
- RVPH -0.01
- RAND 0.24
- Stochastic Oscillator
- RVPH 17.36
- RAND 100.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.